As of 2024-07-27, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 5.56 USD. This relative valuation is based on P/E multiples. With the latest stock price at 144.24 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -96.1%.
The range of the Relative Valuation is 5.18 - 6.34 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.1x - 35.0x | 31.3x |
| Forward P/E multiples | 28.8x - 35.3x | 30.6x |
| Fair Price | 5.18 - 6.34 | 5.56 |
| Upside | -96.4% - -95.6% | -96.1% |
| Date | P/E |
| 2024-07-26 | 803.20 |
| 2024-07-25 | 821.69 |
| 2024-07-24 | 813.00 |
| 2024-07-23 | 822.14 |
| 2024-07-22 | 814.95 |
| 2024-07-19 | 810.83 |
| 2024-07-18 | 800.64 |
| 2024-07-17 | 818.02 |
| 2024-07-16 | 829.60 |
| 2024-07-15 | 850.15 |
| 2024-07-12 | 847.03 |
| 2024-07-11 | 847.03 |
| 2024-07-10 | 831.10 |
| 2024-07-09 | 836.67 |
| 2024-07-08 | 843.49 |
| 2024-07-05 | 844.91 |
| 2024-07-03 | 852.60 |
| 2024-07-02 | 858.67 |
| 2024-07-01 | 872.86 |
| 2024-06-28 | 879.83 |
| 2024-06-27 | 879.60 |
| 2024-06-26 | 873.76 |
| 2024-06-25 | 880.16 |
| 2024-06-24 | 912.40 |
| 2024-06-21 | 894.97 |
| 2024-06-20 | 687.71 |
| 2024-06-18 | 654.41 |
| 2024-06-17 | 650.57 |
| 2024-06-14 | 684.04 |
| 2024-06-13 | 696.06 |
| 2024-06-12 | 668.11 |
| 2024-06-11 | 675.91 |
| 2024-06-10 | 682.64 |
| 2024-06-07 | 686.71 |
| 2024-06-06 | 653.97 |
| 2024-06-05 | 667.05 |
| 2024-06-04 | 666.66 |
| 2024-06-03 | 691.78 |
| 2024-05-31 | 723.13 |
| 2024-05-30 | 693.00 |
| 2024-05-29 | 647.34 |
| 2024-05-28 | 631.08 |
| 2024-05-24 | 687.49 |
| 2024-05-23 | 707.93 |
| 2024-05-22 | 714.44 |
| 2024-05-21 | 719.01 |
| 2024-05-20 | 728.53 |
| 2024-05-17 | 731.59 |
| 2024-05-16 | 739.16 |
| 2024-05-15 | 737.83 |